A number of aptamer-based therapeutics are currently undergoing clinical trials, including therapeutic aptamers for cancer treatment such as AS1411 targeting nucleolin26 and NOX-A12 targeting stroma cell-derived factor-1 (SDF-1)27. The gene discussed is CXCL12; the disease is cancer.